Forgot Your Password?
Complete Story
 

2007 OPA/OSHP Midyear Meeting

November 4, 2007, Marriott Columbus Airport Hotel, Columbus, Ohio

Taking Pharmacy Services to the Next Level
The 2007 Midyear Meeting will afford pharmacists the information, tools, strategies, and solutions they need to improve patient outcomes and enhance medication adherence behaviors in a number of disease states. Jointly sponsored by the Ohio Pharmacists Association and the Ohio Society of Health-System Pharmacists, this meeting will provide information to readily implement in a variety of practice settings.

Choose up to eight contact hours (0.8 CEU) of continuing education credit from the 16 hours offered in clinical, pharmacy practice and legislative topics. The programs are both educational and practical; and the faculty represents leaders in their respective fields. Take advantage of this outstanding learning opportunity. Register TODAY! Space is limited.

Registration FeeEarly BirdAfter 10/12/2007
OPA or OSHP Member$129$139
Non-Member$159$169

For secured online registration, REGISTER TODAY!

SCHEDULE AT A GLANCE
8:00 a.m. Registration and Continental Breakfast

8:30 a.m. Medication Adherence Evaluation and the Pharmacist
Rajesh Balkrishnan, PhD

8:30 a.m. Diagnosis, Management and Prevention of COPD
Thomas J. Boes, M.D.

10:25 a.m. Medications Commonly Involved in Adverse Drug Reactions and Medication Errors
Matthew Grissinger, R.Ph., FISMP, FASCP

10:25 a.m. Current Management of Alzheimer's Disease
Douglas Scharre, M.D.
Sponsor: Forest Pharmaceuticals, Inc.

12:05 p.m. Lunch

1:10 p.m. Oral Chemotherapy Medications: Issues and Opportunities
Brooke Crawford, PharmD, R.Ph.; Niesha Griffith, MS, R.Ph.; Sarah Hudson-Disalle, PharmD, R.Ph.

1:10 p.m. Drug-Eluting Stents in 2007 and the Next Big Things in Cardiology
Steven J. Yakubov, M.D.

3:05 p.m. Optimizing Oral Health
Fred O. Sakamoto, D.D.S.
(note: this is a 50-minute program)

3:05 p.m. Understanding CLIA and OSHA: A Primer for Pharmacists
Trish R. Freeman, R.Ph., PhD
(note: this is a 50-minute program)

4:05 p.m. Celiac Disease for the Pharmacist
Steven Plogsted, PharmD, BCNSP
(note: this is a 50-minute program)

4:05 p.m. Pharmacy Legislation Update
Ernest Boyd, R.Ph., CAE and Kelly Vyzral, OPA Lobbyists
(note: this is a 50-minute program)

5:00 p.m. Adjournment


Program Descriptions

Medication Adherence Evaluation and the Pharmacist
Rajesh Balkrishnan, PhD
Merrell Dow Professor, The Ohio State University College of Pharmacy and School of Public Health
ACPE # 129-000-07-054-L04-P 0.2 CEU
The purpose of this session is to educate the audience about recent findings related to medication use behaviors in chronically ill patients. The session will also explore how the pharmacist can play an important role in enhancing medication adherence behaviors and optimizing patient outcomes in chronic medical conditions which require controller pharmacotherapy.

Diagnosis, Management and Prevention of COPD
Thomas J. Boes, M.D.
ACPE # 129-000-07-055-L01-P 0.2 CEU
Chronic obstructive pulmonary disease(COPD) is a treatable and preventable disease, yet it remains a leading cause of morbidity and mortality worldwide. This session will review the pathophysiology and differential diagnosis of COPD, as well as co-morbidities and risk factors associated with the disease. Evidence-based guidelines for use of pharmacotherapy and non-pharmacologic treatment for the management of stable COPD and exacerbations will be included.

Medications Commonly Involved in Adverse Drug Reactions and Medication Errors
Matthew Grissinger, R.Ph., FISMP, FASCP
Director, Error Reporting Programs
Institute for Safe Medication Practices
ACPE # 129-000-07-056-L01-P 0.2 CEU
No one wants to be part of medication errors or adverse drug reactions. This session examines the drugs most frequently associated with adverse reactions and the drugs most frequently associated with medication errors. Strategies for avoiding patient harm that might result from these adverse reactions and medication errors will be discussed.

Current Management of Alzheimer's Disease
Douglas W. Scharre, M.D.
Associate Professor of Clinical Neurology, Memory Disorders Clinic, Department of Neurology, The Ohio State University
ACPE # 129-000-07-057-L01-P 0.2 CEU
Alzheimer's disease is a progressive, degenerative brain disease characterized by an increasing loss of memory and other cognitive functions, which is challenging for the patient as well as the caregiver. This program will focus on the pathophysiology and diagnosis of Alzheimer's disease, current treatment options, and future therapies in clinical trials. Our speaker will also include support group resources to share with pharmacists for patient referral.
Sponsor: Forest Pharmaceuticals, Inc.

Oral Chemotherapy Medications: Issues and Opportunities
Brooke Crawford, PharmD, R.Ph. and Sarah Hudson-DiSalle, PharmD, R.Ph.
Specialty Practice Pharmacists, Arthur G. James Cancer Hospital;
Niesha Griffith, MS, R.Ph., Associate Director, Department of Pharmacy, OSU Medical Center
ACPE # 129-000-07-058-L01-P 0.2 CEU
Advances in the treatment of cancer include new oral chemotherapy agents that differ from agents that have historically been used. This session will review the mechanisms of action, possible drug interactions and adverse events of the newer oral chemotherapeutic agents. Advantages and barriers for both patients and caregivers when administering oral chemotherapy, as well as payment issues, will be included.

Drug-Eluting Stents in 2007 and the Next Big Things in Cardiology
Steven J. Yakubov, M.D.
MidOhio Cardiology and Vascular Consultants, Inc., Columbus
ACPE # 129-000-07-059-L01-P 0.2 CEU
This session will provide an overview of the use of drug-eluting stents and medication regimens in patients with coronary artery disease. Controversies surrounding use of drug-eluting vs. bare metal stents, current recommendations for medications following stent placement, and future advances in cardiology will be addressed. Case-studies of patients with angina and/or recent history of myocardial infarction will be included.

Optimizing Oral Health
Fred O. Sakamoto, D.D.S.
Central Ohio Periodontics
ACPE # 129-000-07-060-L01-P 0.1 CEU
Our speaker will provide an overview of oral health concerns that patients may present to their pharmacist. Use of fluoride containing products, changing recommendations for antimicrobial prophylaxis prior to dental procedures, osteonecrosis of the jaw following use of bisphosphonates, as well as selection of tooth whitening products, antimicrobial mouth rinses and toothpastes will be addressed.

Understanding CLIA and OSHA: A Primer for Pharmacists
Trish R. Freeman, R.Ph., PhD
Director, Professional Practice Programs
University of Kentucky College of Pharmacy
ACPE # 129-000-07-061-L04-P 0.1 CEU
This program will provide pharmacists with an overview of the Clinical Laboratory Improvement Act (CLIA) as it relates to conducting pharmacy-based CLIA-waived tests and the Occupational Safety and Health Administration (OSHA) regulations that pertain to blood-borne pathogen exposure for pharmacists collecting samples for laboratory testing and those providing adult immunizations.

Celiac Disease for the Pharmacist
Steven Plogsted, PharmD, BCNSP
Nutrition Support Pharmacist, Columbus Children's Hospital
ACPE # 129-000-07-062-L01-P 0.1 CEU
Celiac disease is a digestive condition whose symptoms can mimic many other conditions. This session will define celiac disease, discuss the symptomatology, and address diagnosis and treatment options. Our speaker will also help identify sources of gluten contamination.

Pharmacy Legislation Update
Ernest Boyd, R.Ph., CAE and Kelly Vyzral
OPA Lobbyists, Columbus
ACPE # 129-000-07-063-L04-P 0.1 CEU
Significant pharmacy legislation has passed in the Ohio Legislature and in Congress this year. You will learn how these legislative changes impact your practice and your patients. The latest updates from the state legislature will be a part of this important program. This session will also include an update of the tamper-evident prescription blank mandate for Medicaid prescriptions, and Ohio's efforts in this regard
Note: This program is NOT approved for Ohio jurisprudence CE credit.

For secured online registration, REGISTER TODAY!


Continuing Education Credit
This meeting is targeted to all pharmacists. The continuing education for this program is coordinated by the Ohio Pharmacists Foundation (OPF). The mission of the Ohio Pharmacists Foundation is to provide educational programs for pharmacists and consumers of health care that enhance the practice of pharmacy and patient outcomes, and to conduct research to support these efforts.

To receive continuing pharmacy education credit, you must complete the CE form indicating programs attended. Sign, date, and return the CE form to the OPA staff or office. Your statement of CE credit will be mailed to you within four weeks.

$$Link
http://www.ohiopharmacists.org/pdf_files/MidYearProgLearningObj
2007 Midyear Program Learning Objectives
0$$

The Ohio Pharmacists Foundation, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.


Hotel Information
The Marriott Columbus Airport is located at 1375 N. Cassady Avenue in Columbus. Rate: $105 a night. Reservations can be made by calling 614.475.7551 or 800.491.5717. Reservation requests after October 13, 2007 are subject to availability and may not be at the conference rate.
Request for refunds, less $15 administrative fee, will be honored if received by 10/26/2007.


< Back | Printer Friendly Page
Get OPA Events via RSS

Events

 September 2014 
SMTWTFS
 123456
78910111213
1415161718
1920
2122232425
26
27
282930